share_log

海翔药业(002099.SZ):目前套保比例持续维持在低位,对公司未来业绩的影响将减小

Haixiang Pharmaceutical (002099.SZ): Currently, the hedging ratio continues to remain low, and the impact on the company's future performance will decrease

Gelonghui Finance ·  May 20 21:41

Gelonghui, May 21丨Haixiang Pharmaceutical (002099.SZ) Investor Relations Activity Record Form shows that the company's foreign export business is high, and the main purpose of the company hedging a certain percentage of US dollar assets is to reduce the uncertain impact of large exchange rate fluctuations and improve the company's resilience to risks. Currently, the hedging ratio continues to remain low, and the impact on the company's future performance will decrease.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment